Accorto Regulatory Solutions Launches Dedicated Quality & Compliance Division
Richmond, Virginia - February 2, 2026 [...]
From QSR to QMSR: Understanding FDA’s Alignment with ISO 13485
January 26, 2026 The Quality [...]
Navigating FDA’s Pre-Submission Process: Strategies for Effective Early Regulatory Engagement
October 10, 2025 For medical [...]
FDA’s Final Guidance on Computer Software Assurance: A New Era for Medical Device Manufacturing
September 26, 2025 On September [...]
FDA Issues Final Guidance on Enforcement Discretion for In Vitro Diagnostic Tests in Declared Emergencies
September 23, 2025 On September [...]
FDA Officially Rescinds the LDT Final Rule
September 19, 2025 On September [...]
A New Chapter in U.S. Nicotine Policy: Kennedy Signals Shift Toward Tobacco Harm Reduction
July 31, 2025 The U.S. [...]
Accorto’s Perspective: FDA’s JUUL Decision Signals Path Forward for Committed Applicants
July 24, 2025 We are [...]
JUUL Labs’ Statement On FDA Marketing Authorizations
The Following Press Release Was Provided by JUUL Labs [...]
FDA Pauses Overseas Genetic Engineering Trials: What It Means for the Industry
June 19, 2025 On June [...]
